The Exchange has sought clarification from Bodal Chemicals Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted in XBRL with discrepancies The response of the Company is awaited.
BODALCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
NSE has asked Bodal Chemicals to clarify discrepancies found in the XBRL-formatted financial results submitted for the quarter ended March 31, 2025. The query is raised under Regulation 33 of SEBI's Listing Obligations and Disclosure Requirements. The company has not yet responded to the exchange, and its reply is awaited. No details on the nature of the discrepancies have been shared publicly so far.
This is a routine compliance query and not a punitive action. Investors should wait for the company's clarification to understand the nature of the discrepancy, but it is unlikely to affect the stock price unless the company fails to respond or the issue escalates.